Annual report pursuant to Section 13 and 15(d)

Net (Loss) Income Per Share Of Common Stock, Basic And Diluted - Narrative (Details)

v3.20.1
Net (Loss) Income Per Share Of Common Stock, Basic And Diluted - Narrative (Details)
 3 Months Ended 12 Months Ended
Dec. 27, 2018
$ / shares
shares
Dec. 26, 2018
shares
Dec. 31, 2018
$ / shares
shares
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2018
USD ($)
$ / shares
shares
Dec. 31, 2014
shares
Anti-dilutive securities            
Preferred stock, shares authorized (in shares)     5,000,000 5,000,000 5,000,000  
Deemed distribution to shareholder | $         $ 1,657,383  
Net loss | $       $ (16,072,547) (40,052,810)  
Net (loss) income attributable to common shareholders | $         $ 41,700,000  
Private Placement            
Anti-dilutive securities            
Number of shares available under warrant (in shares) 14,285,714          
Exercise price per share (in dollars per share) | $ / shares $ 0.40          
Series B convertible preferred stock | Preferred Stock            
Anti-dilutive securities            
Preferred stock conversion ratio 0.20 0.20 0.20 0.20    
Preferred stock, days outstanding         5 days  
Number of shares available under warrant (in shares)           625,208
Series B convertible preferred stock | Preferred Stock | Private Placement            
Anti-dilutive securities            
Preferred stock, shares authorized (in shares)   2,857,143 2,857,143   2,857,143  
Incentive Warrants            
Anti-dilutive securities            
Number of shares available under warrant (in shares)     4,000,000   4,000,000  
Expected life 5 years 6 months   5 years 6 months   5 years 6 months  
Exercise price per share (in dollars per share) | $ / shares $ 12.50   $ 12.50   $ 12.50  
Deemed distribution to shareholder | $         $ 1,700,000